ANALYSIS of the cellular requirements for the induction of immune responses and the development of their effector phase has been greatly facilitated by in vitro methods of lymphocyte culture. Thus the interactions taking place during the development of a cytotoxic T-cell response to allogeneic tissues are becoming more clearly understood (Gordon et al., 1975; Simpson et al., 1975; Wagner et al., 1972) .
In vitro culture techniques have also been used to generate cytotoxic lymphocytes reactive towards tumour-associated cellsurface antigens (Kupermann et al., 1975a, b; Kall & Hellstrom, 1975; Chism et al., 1976) . During studies of the induction and in vitro boosting of immune responses to syngeneic rat tumours, it was observed that culture of lymphnode cells from rats bearing a transplanted methylcholanthrene-induced rat sarcoma produced a cell population highly cytotoxic for tumour cells. This paper describes investigations into the nature and characteristics of this cytotoxic effect. These findings may have relevance in two areas: firstly, the development of this effect could obscure the detection of other responses, for example specific T-cellmediated cytotoxicity, and confuse the interpretation of cultured lymphocyte cytotoxicity data, and secondly if this antitumour effect functions in vivo it may have therapeutic potential.
MATERIALS AND METHODS
Rats and tumours.-Hepatomas, (D23, D192A, D202) were induced in inbred WAB/ Not rats by oral administration of 4-dimethylaminoazobenzene (Baldwin & Barker, 1967) and sarcomas (Mc7, Mc57) by s.c. injectioIn of 3-methylcholanthrene. Tumours were serially passaged by implanting tumour fragments s.c. in syngeneic recipients of the same sex.
In vitro cell lines.-Single-cell suspensions were prepared by trypsin digestion (0.25% Lymph-node cells (LNC).-The cervical, axillary, inguinal and mesenteric lymph nodes were removed aseptically from normal control and tumour-bearing rats, and pressed through a 120-gauge stainless-steel wire gauze into Hanks' balanced salt solution containing 2% foetal calf serum (HBSS). In these studies tumour grafts were implanted s.c. by trocar into rats, and LNC prepared from the animals 14-21 days later, when the mean diameter of the tumour was 2-3 cm.
The lymphnode cells were then centrifuged at 120 g for 5 min, and washed x 3 in HBSS before use. In vitro LNC culture conditions.-LNC from normal rats or rats bearing transplanted sarcoma Mc7 were cultured in the 16mm wells of cluster plates (Costar) in 1-5 ml Eagle's MEM containing 10% foetal calf serum (MEM-FCS) and 10-5M 2-mercaptoethanol (2ME). Plates were incubated at 37°C in a 5% CO2 atmosphere. Cultured cells were recovered by gentle resuspension, washed twice by centrifugation at 200 g for 10 min in HBSS and resuspended in MEM-FCS medium. These cultured effector cells were then tested for cytotoxicity to rat target cells, and also used to prepare supernatant material. This procedure gave yields of 40-50% of the cell number initially placed in culture.
Preparation of supernatant (SN).-Supernatants were prepared from fresh or cultured LNC from normal or tumour-bearing rats. LNC in MEM-CS were cultured in 7ml flatbottomed plastic bijou bottles (Sterilin, Teddington, Middlesex) at 2 x 106 viable cells/ml in 1 -2ml cultures. After incubation at 37°C in a 5% CO2 atmosphere for 48 h, the medium was removed, the cells sedimented by centrifuging at 500 g for 10 min and the supernatant collected and filtered through a Millex disposable filter (0 22ptm pore size).
Medium alone was treated in a similar manner to provide "cultured medium" control. The harvested supernatants were diluted in MEM-CS and assayed for toxicity to rat target cells.
Measurement of the activity of whole LNC and their supernatants against rat target cells.-Target cells were plated at 500-1000/well into flat-bottomed microtest II plates (Cooke M29ART, supplied by Dynatech Laboratories, Billingshurst, Sussex) in 0-1 ml of MEM-CS and incubated at 37°C for 24 h before testing. LNC (freshly prepared or cultured) from normal and tumour-bearing rats were added in a volume of 0.1 ml MEM-CS without removing the plating medium. After incubation at 37°C for 48 h, the target cells were pulse-labelled with radio-labelled cell precursors at the following concentrations: 1 251-iododeoxyuridine (1 25I-IUdR) final concentration 10 nmol (0.8 ,uCi) per ml, 3H-leucine final concentration 1 6 ,umol (6 ,Ci) per ml and 75Se-L-selenomethionine final concentration 0.5 ,umol (1-5 ,Ci) per ml (10 pl per well) (Brooks et al., 1978) . 3H-leucine and 75Se-L-selenomethionine were added directly to the wells; they have previously been shown to be reliable indicators of cell survival (Brooks et al., 1978) . It was however necessary to replace the medium in wells before labelling with 1251-UdR to avoid competition due to nucleoside released from either the target cells or lymphocytes. Supernatant material, prepared from LNC cultures, was incubated with target cells for 48 h before radio-labelling with either 3H-leucine or 75Se-L-selenomethionine. The reactivity of both whole LNC and their supernatants was calculated by comparing the uptake of isotope in wells treated with LNC or SN with the uptake of label by cells incubated with medium alone. In certain experiments the cytotoxicity of tumour-bearing rat LNC was calculated from the formula:
where a=uptake of isotope after culture with normal rat LNC, and b=uptake after culture with tumour-bearing rat LNC.
The chromium-51 (51Cr) release test was performed in V-bottomed microtest II plates, using 5000 51Cr-labelled cells per well and rat LNC. The plates were centrifuged, and the mixture incubated for 3 or 15 h at 37°C. The contents of the wells were suspended, and after centrifugation half of the supernatant was removed and counted in a gamma spectrometer. The residual activity in the cell pellet and remaining supernatant was similarly determined. The per cent isotope release was calculated by the formula: % release= 2a x 100 a+b where a=counts in 1/2 supernatant and b=counts in pellet and remaining supernatant.
RESULTS
Development of tumour-bearer LNC cytotoxicity after in vitro culture After in vitro culture, in the absence of a sensitizing cell population, LNC from tumour-bearing (TB) rats developed increased levels of cytotoxicity to rat tumour cells. The results presented in Table I and Fig. 1 important, since it allowed sequential tests to be performed on the same pool of reactive LNC.
In studying the kinetics of cytotoxicity by cultured TB LNC, it was found that target-cell lysis did not occur during the first 15h of incubation, as shown by the absence of isotope release from 51Cr-labelled target cells in 3h or 15h assays. By contrast, high levels of cytotoxicity could be demonstrated in a 48h assay in which target cells were post-labelled with radioactive nucleosides or amino acids (Fig. 1) . Visual observation indicated that cell lysis and/or cell detachment, rather than growth inhibition, was occurring, since no target cells could be seen in wells in which subsequent measurement of isotope incorporation indicated 100% cytotoxicity. In these studies cultured normal rat LNC rarely showed cytotoxicity for Mc7 target cells; some cytotoxicity was occasionally detected using high numbers of normal LNC, but was very small compared with the cytotoxicity shown by cultured TB LNC. Fig. 2 shows the development of cytotoxicity by sarcoma-Mc7-bearer LNC after various culture times up to 7 days. Maximum cytotoxicity was shown 4-7 days after in vitro culture. Normal LNC again only showed significant cytotoxicity at the highest effector: target cell ratios used, at 4 and 7 days after initiation of culture.
Detection of a cytotoxic supernatant factor or factors from in vitro cultured rat LNC Investigations into the mechanism of non-specific in-vitro-generated cytotoxicity displayed by Cytotoxicity could also be seen, and was shown to be cross-reactive with cells derived from a chemically induced rat hepatoma (D202) as well as normal rat fibroblasts. However, cytotoxic events were not detected in either a 3h or 15h 51Cr-release test. This may reflect an increased susceptibility of adherent target cells to cytotoxic mechanisms, but a more likely explanation is that target cells do not die during the early stages of coculture of target cells and effector cells. Evidence was obtained that the mechanism of cytotoxicity involved the release of a cytotoxic factor from the cultured TB LNC, and because the release of this factor was rapid, beginning within 2 h of re-culture, the requirement for a long-term cytotoxicity assay would appear to be due to the slow death of target cells after interaction with this factor.
A number of other workers have demonstrated augmented cytotoxicity in cultured lymphocytes. In one series of reports, increased cytolytic activity was found after short-term culture (3-24 h) of lymphocytes from tumour-bearer or tumour-immune animals (de Landazuri & Herberman, 1972; Laux & Lausch, 1974; Vasudevan et al., 1974; Gorczynski & Tigelaar, 1975; Shellam et al., 1976) , such in vitro activated cells being apparently capable of causing specific tumour rejection in vivo (Blasecki & Trevethia, 1975) . In the mouse studies, the cytotoxic cells were shown to be sensitive to anti-6 serum (Vasudevan et al., l1974; Gorezinski & Tigelaar, 1975 ) and were therefore not NK cells (Herberman & Holden, 1978) . This type of activation of cytotoxicity was clearly demonstrable within 24 h of culture, and the cytotoxic cells showed elements of specificity in vitro in both short-term (Ortiz de Landazuri & Herberman, 1972; Laux & Lausch, 1974; Vasudevan et al., 1974) and long-term (Wright et al., 1 973) cytotoxicity assays. Burton et al. (1977) and Shustik et at. (1976) have described a different cytotoxic activity which developed in normal mouse spleen cells over a 5-day culture period and was of broad specificity. Ortaldo et al. (1977) made similar observations with human peripheral blood cells, and showed that in this system the cytotoxicity was generated by substances in foetal calf serum, suggesting some kind of mitogenic or antigenic activation. Indeed, these workers, and subsequently others (Callewaert et al., 1978) demonstrated that stimulation of human peripheral blood lymphocytes with phytohaemagglutinin, PPD, or allogeneic cells induced high levels of spontaneous cytotoxicity, which was mediated by an Fc+ cell (Ortaldo et al., 1977) . A third type of cytotoxicity developing in culture has been described by Muchmore et al. (1977a) , human peripheral blood cells developing spontaneous cytotoxicity towards red blood cells when cultured alone for 7 days. It was claimed that activation occurred in human serum as well as in foetal calf serum and that the effector cell was Fc-. In our own system, preliminary experiments have shown that foetal calf serum does play a role, in so far as considerable differences in cytotoxicity were found after culture of TB LNC in medium containing different batches of serum (Robins, unpublished observation), but whether this was due to nutritional or antigenic/mitogenic differences between batches of serum is not yet known. It is already clear, however, that there are a number of interesting differences between the phenomenon we have observed and those noted above.
Firstly, we could not detect any cytotoxic activity in a short-term chromiumrelease assay, whereas in all the other reports reactivity was readily demonstrable in such an assay. This may either reflect a difference in the rate at which different target cells are killed, or indicate that different lytic mechanisms are operative. Secondly, we were able to show that the effector cells in our system released a cytotoxic substance, which was not the case in the systems studied by Burton et al. (1977) and Muchmore et al. (1977a) , in which addition of moderate numbers of cold target cells inhibited cytotoxicity. Thirdly, we found that augmentation of cytotoxicity during culture generally occurred only with LNC from tumourbearer animals and not with LNC from normal animals. Tumour growth therefore played an important part in the induction of the cytotoxic cells. It is interesting to note that the activity of conventional NK cells (Herberman & Holden, 1978) can be augmented by certain in vivo treatments, including the inoculation of tumour cells Oehler et al., 1978) . However, tumour growth itself has been reported to depress NK-cell activity (Becker & Klein, 1976; Pross & Bains, 1976) . Our own studies, using a long-term cytotoxicity assay and target cells derived from solid tumours, have indicated the existence of a second "natural killer" cell, which is characterized by its relatively high affinity for nylon wool (Brooks et at., 1976) . The activity of these cells, which is often masked by the growth-promoting activities of other cell types, and is only detectable at high lymphocyte: tumour cell ratios, may be partly mediated by a rapidly released toxic factor, which we have recently shown to be heat-stable (Rees & Brooks, unpublished observation) . It is possible that the effector cell in cultured TB LNC is of the same type, being stimulated in vivo by the growth of a tumour and revealed by in vitro culture either as a result of further stimulation or the loss of some type of suppressor cell. A precedent for this latter postulate has recently been described by Muchmore et al. (1977b) .
The characteristics of the cytotoxic factor we have described are at present unknown, apart from its heat-stability and some preliminary data indicating a mol. wt > 10,000 (Robins, unpublished). It is therefore not possible to make a meaningful comparison with the legion of cytotoxic factors reported previously in the literature. However, it is worth noting that a malignant cell isolated from human peripheral blood, which had characteristics similar to those of NK cells, released a cytotoxic factor into the culture medium which was claimed to have anti-tumour activity in vivo (Karpas, 1978) . Whether the factor described in the present study is also active in vivo remains to be determined.
